Foresee Pharmaceuticals Co LtdEigentümerstruktur
| Preis (2026-07-28) | 52W Hoch | 52W Tief |
| 80.7 TWD | 93,7 TWD | 71,9 TWD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - TWD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 157.540.541 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Foresee Pharmaceuticals Co Ltd
Mitarbeiter 0
Handelsplatz TWO
Ticker Symbol 6576
IPO Datum -
Adresse No. 19-3, Sanchong Road, Taipei, Taiwan, 115
Webseite https://www.foreseepharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Benjamin Chien Ph.D. | Founder, CEO & Chairman |
| 2 | Dr. Yuhua Li Ph.D. | Co-founder & CTO |
| 3 | Dr. Mathieu Boudreau Ph.D. | COO & Chief Business Officer |
| 4 | Dr. Yisheng Lee M.B.A., M.D., Ph.D. | Chief Medical Officer & Director |
| 5 | Dr. Jagdish Parasrampuria Ph.D. | Senior Vice President of Pharmaceutics & Manufacturing |
| 6 | Dr. Bassem Elmankabadi M.D. | Senior Vice President of Clinical Development |
| 7 | Mr. MengKung Chan M.B.A. | Chief Financial Officer |
| 8 | Ning Ya Chen | Accounting Supervisor |
| 9 | Dr. Wenjin Yang Ph.D. | Chief Scientific Officer and Director of New Drugs and R&D |
| 10 | Mr. Ruo Hua Huang | Deputy Manager of Investor Relations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.